Contact: Karen Kreeger
University of Pennsylvania School of Medicine
Caption: Kurt Brunden, Ph.D., Director of Drug Discovery at Penn's Center for Neurodegenerative Disease Research, explains a new Journal of Neuroscience study which shows that the compound epothilone D is effective in preventing further neurological damage and improving cognitive performance in a mouse model of Alzheimer's disease. The results establish how the drug might be used in early-stage AD patients.
Credit: Perelman School of Medicine, University of Pennsylvania
Usage Restrictions: None
Related news release: Potential Alzheimer's disease drug slows damage and symptoms in animal model